Literature DB >> 7624953

Heteroagglutinins and their significance in baboon hepatic xenotransplantation.

D J Triulzi1, E A Jochum, I R Marino, T E Starzl.   

Abstract

The role of preformed xenoreactive antibodies in xenograft recipients is unknown. Humans and baboons possess red cell agglutinating activity associated with isohemagglutinins and heteroagglutinins (HA). We examined the role of HA in two patients who received ABO-identical baboon livers. Human antibaboon HA were assessed by correlating serial titers with studies for rejection. Serial direct antiglobulin testing (DAT) was used to detect baboon antihuman HA, potentially produced by transplanted passenger lymphocytes. Patient 1 survived 70 days. The human antibaboon HA titers remained essentially unchanged from preoperative values. Although hyperacute rejection did not occur, and there was only mild cellular rejection, liver function was suboptimal. Postreperfusion immunoglobulin and complement deposition and histologic changes suggested complement-mediated injury. DAT testing was negative except for passively acquired anti-A from transfusion. At autopsy there was marked bile stasis, but no rejection. Patient 2 survived 26 days with essentially unchanged HA titers until preterminal. Although there was no hyperacute rejection and only mild humoral rejection (without cellular rejection), suboptimal liver function and bile stasis were again noted. Postreperfusion immunoglobulin and complement deposition again suggested complement-mediated injury. DAT testing was negative. At autopsy there was no rejection. Human antibaboon HA do not appear to be associated with hyperacute or cellular rejection, but their role in the complement-mediated injury, suspected in both cases, cannot be definitively excluded. Baboon antihuman HA were not detected in either patient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624953      PMCID: PMC3005252          DOI: 10.1097/00007890-199507000-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES.

Authors:  T E STARZL; T L MARCHIORO; G N PETERS; C H KIRKPATRICK; W E WILSON; K A PORTER; D RIFKIND; D A OGDEN; C R HITCHCOCK; W R WADDELL
Journal:  Transplantation       Date:  1964-11       Impact factor: 4.939

2.  BLOOD GROUPS OF APES AND MONKEYS: I. THE A-B-O BLOOD GROUPS IN BABOONS.

Authors:  J MOOR-JANKOWSKI; A S WIENER; E B GORDON
Journal:  Transfusion       Date:  1964 Mar-Apr       Impact factor: 3.157

3.  The A-B-O blood groups of baboons.

Authors:  A S Wiener; J Moor-Jankowski
Journal:  Am J Phys Anthropol       Date:  1969-01       Impact factor: 2.868

4.  Experience with primary liver transplantation across ABO blood groups.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; S Todo; L Makowka; A Tzakis; J W Marsh; T E Starzl
Journal:  Transplant Proc       Date:  1987-12       Impact factor: 1.066

Review 5.  The biological basis of and strategies for clinical xenotransplantation.

Authors:  T E Starzl; L A Valdivia; N Murase; A J Demetris; P Fontes; A S Rao; R Manez; I R Marino; S Todo; A W Thomson
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

6.  ABH antigens in vascular endothelium and some epithelial tissues of baboons.

Authors:  R Oriol; J E Cooper; D R Davies; P W Keeling
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

Review 7.  Prospects of clinical xenotransplantation.

Authors:  T E Starzl; A Tzakis; J J Fung; S Todo; A J Demetris; R Manez; I R Marino; L Valdivia; N Murase
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

8.  Isohemagglutinins of graft origin after ABO-unmatched liver transplantation.

Authors:  G Ramsey; J Nusbacher; T E Starzl; G D Lindsay
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

9.  Immunohematologic complications of ABO-unmatched liver transplants.

Authors:  D J Triulzi; R S Shirey; P M Ness; A S Klein
Journal:  Transfusion       Date:  1992 Nov-Dec       Impact factor: 3.157

10.  Baboon-to-human cardiac xenotransplantation in a neonate.

Authors:  L L Bailey; S L Nehlsen-Cannarella; W Concepcion; W B Jolley
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

View more
  1 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.